 |
Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies
Abstract : Between September 2017 and February 2018, influenza A(H1N1)pdm09, A(H3N2) and B viruses (mainly B/Yamagata, not included in 2017/18 trivalent vaccines) co-circulated in Europe. Interim results from five European studies indicate that, in all age groups, 2017/18 influenza vaccine effectiveness was 25 to 52% against any influenza, 55 to 68% against influenza A(H1N1)pdm09, -42 to 7% against influenza A(H3N2) and 36 to 54% against influenza B. 2017/18 influenza vaccine should be promoted where influenza still circulates.
Cited literature [34 references]
https://hal.umontpellier.fr/hal-01976967
Contributor : Anthony Herrada <>
Submitted on : Thursday, January 10, 2019 - 2:20:14 PM
Last modification on : Friday, June 7, 2019 - 10:50:06 AM
Document(s) archivé(s) le : Thursday, April 11, 2019 - 3:30:41 PM
Contributor : Anthony Herrada <>
Submitted on : Thursday, January 10, 2019 - 2:20:14 PM
Last modification on : Friday, June 7, 2019 - 10:50:06 AM
Document(s) archivé(s) le : Thursday, April 11, 2019 - 3:30:41 PM
File
eurosurv-23-9-1.pdf
Publisher files allowed on an open archive
